These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21354260)

  • 1. Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: a high resolution PET study.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    Biol Psychol; 2011 Apr; 87(1):164-7. PubMed ID: 21354260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [¹¹C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Kim YB; Cho ZH
    Acta Neuropsychiatr; 2014 Feb; 26(1):35-42. PubMed ID: 25142098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age on dopamine D2 receptor availability in striatal subdivisions: a high-resolution positron emission tomography study.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):885-91. PubMed ID: 21511442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.
    Martinez D; Broft A; Foltin RW; Slifstein M; Hwang DR; Huang Y; Perez A; Frankle WG; Cooper T; Kleber HD; Fischman MW; Laruelle M
    Neuropsychopharmacology; 2004 Jun; 29(6):1190-202. PubMed ID: 15010698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine type 2 receptor availability in anorexia nervosa.
    Broft A; Slifstein M; Osborne J; Kothari P; Morim S; Shingleton R; Kenney L; Vallabhajosula S; Attia E; Martinez D; Timothy Walsh B
    Psychiatry Res; 2015 Sep; 233(3):380-7. PubMed ID: 26272038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between subcortical brain volume and striatal dopamine D
    Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
    Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humans.
    Caravaggio F; Fervaha G; Chung JK; Gerretsen P; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):644-52. PubMed ID: 26944295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
    Ledermann K; Jenewein J; Sprott H; Hasler G; Schnyder U; Warnock G; Johayem A; Kollias S; Buck A; Martin-Soelch C
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced striatal dopamine D2 receptors in people with Internet addiction.
    Kim SH; Baik SH; Park CS; Kim SJ; Choi SW; Kim SE
    Neuroreport; 2011 Jun; 22(8):407-11. PubMed ID: 21499141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET study.
    Nakajima S; Caravaggio F; Mamo DC; Mulsant BH; Chung JK; Plitman E; Iwata Y; Gerretsen P; Uchida H; Suzuki T; Mar W; Wilson AA; Houle S; Graff-Guerrero A
    Schizophr Res; 2015 May; 164(1-3):263-7. PubMed ID: 25757713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
    Alakurtti K; Aalto S; Johansson JJ; Någren K; Tuokkola T; Oikonen V; Laine M; Rinne JO
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):155-65. PubMed ID: 20442726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of striatal dopamine D2 receptors in nonhuman primates: increases in availability produced by chronic raclopride treatment.
    Czoty PW; Gage HD; Nader MA
    Synapse; 2005 Dec; 58(4):215-9. PubMed ID: 16206180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.
    Cervenka S; Gustavsson JP; Halldin C; Farde L
    Neuroimage; 2010 Mar; 50(1):323-8. PubMed ID: 20004254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
    Hirvonen M; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
    Mol Psychiatry; 2004 Dec; 9(12):1060-1. PubMed ID: 15278099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.